The COVID-19 pandemic has prompted the rapid development and administration of various vaccines worldwide, with some reports linking these vaccines to immune thrombotic thrombocytopenic purpura (TTP).
Aurora Q3 Cannabis Sales Slip 3% to C$53.3 Million
Aurora Cannabis Announces Fiscal 2023 Third Quarter and Files Full Year Results Achieves Second Sequential Quarter of Positive Adjusted EBITDA1 Net Revenue Reaches $64 Million,